Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3

Status

Unknown 3Completed 3

Sponsor Class

OTHER 29NETWORK 12NIH 6INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 6

Conditions

Lymphoma 13HIV Infections 8Acquired Immunodeficiency Syndrome 8Testicular Neoplasms 6Hodgkin Disease 6Teratoma 5Lymphoma, Non-Hodgkin 5Testicular Germ Cell Tumor 4Sarcoma, Kaposi 4Lymphoma, Large B-Cell, Diffuse 3Endodermal Sinus Tumor 3Carcinoma, Embryonal 3Seminoma 2Recurrence 2Ovarian Neoplasms 2Ovarian Germ Cell Cancer 2Lymphoma, Large-Cell, Immunoblastic 2Teratoma, Testicular 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nervous System Neoplasms 1Melanoma 1Lymphoma, Follicular 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Head and Neck Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1AIDS-Related Complex 1

Interventions

Filgrastim 13Cyclophosphamide 13Etoposide 12Doxorubicin 11fludarabine phosphate 10Vincristine 10Cyclosporine 10Peripheral Blood Stem Cell Transplantation 9Radiotherapy 8Prednisone 8Vinblastine 6Tacrolimus 6Rituximab 6Methotrexate 6Gemcitabine 6Bleomycin 6tanespimycin 5Vorinostat 5Ipilimumab 5Bortezomib 5temsirolimus 4Sirolimus 4Nivolumab 4Mycophenolic Acid 4Melphalan 4Magnetic Resonance Spectroscopy 4Ifosfamide 4Dacarbazine 4Cytarabine 4CTLA-4 Antigen 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
NIH × Hodgkin Disease × Bleomycin × Clear all
NCT00000626 2021-10-27

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
27 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Hodgkin Disease, HIV Infections

NCT00002987 2013-12-04

Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease

National Cancer Institute (NCI)

Phase 3 Unknown
400 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00003421 2013-12-04

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease

National Cancer Institute (NCI)

Phase 3 Completed
800 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00003262 2013-09-20

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

National Cancer Institute (NCI)

Phase 2 Unknown
30 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00041210 2013-09-20

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
850 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT00002714 2013-05-15

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

National Cancer Institute (NCI)

Phase 2 Completed
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡